Resumen
Antiphospholipid syndrome (APS) is characterized by the occurrence of thrombotic events and/or obstetric complications in the presence of antiphospholipid antibodies. It is considered one of the most common acquired thrombophilias. The presentation of stroke in patients with APS has been described in some studies; however, it is not frequent enough and there is not much information available regarding the indications for pharmacological thrombolysis and the safety of thrombolytic treatment. Likewise, current evidence does not describe contraindications to thrombolytic therapy in cases of this diagnosis, which makes management with fibrinolysis safe in these cases. A clinical case of stroke is presented in which pharmacological thrombolysis is performed with a successful outcome, without complications of angioedema or bleeding. Likewise, concerning the case, the main neurological manifestations associated with APS, especially in its association with stroke, are described.
Idioma original | Inglés |
---|---|
Publicación | Cureus |
Volumen | 16 |
N.º | 3 |
Estado | Publicada - mar. 2024 |
Palabras clave
- antiphospholipid antibody
- antiphospholipid syndrome
- emergency medicine
- stroke
- thrombophilias
Tipos de Productos Minciencias
- Artículos de investigación con calidad D